Paradigm is not currently recruiting for clinical trials. Results for the two trials listed here that have recently closed will be published via ASX announcements and on our website.
Phase 2 clinical trial for patients with BMLs and Osteoarthritis
A phase 2b, randomised double blind placebo controlled multicentre study to evaluate the effects of pentosan polysulfate sodium on treating pain in subjects with osteoarthritis of the knee and subchondral bone marrow lesions. Details can be found on the ANZCTR website here.
Update 18 December 2018
Paradigm Biopharma is pleased to announce that it has met its primary endpoint of its phase 2b randomised double-blind placebo-controlled multi-centre clinical trial. Please see our ASX announcements and the video below for more information.